Evidence map›Paper›PMID 35110244›Full record

ArticleTurkish thoracic journal2021

What are the Differences Between Smoker and Non-smoker COPD Cases? Is it a Different Phenotype?

Filiz Güldaval, Gülru Polat, Sibel Doruk, Gülistan Karadeniz, Aysu Ayranci, Merve Türk, Mine Gayaf, Melike Yüksel Yavuz, Melih Büyükşirin, Ceyda Anar

Open access · diamondAbstract read
In one paragraph

Article in Turkish thoracic journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Increased Incidence of Chronic Obstructive Pulmonary Disease in Women Due to Long-Term Passive Smoking.International journal of chronic obstructive pulmonary disease · 2025
    Article
  4. Article
  5. Article
  6. Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients.International journal of chronic obstructive pulmonary disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Filiz GüldavalDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Gülru PolatDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Sibel DorukDepartment of Pulmonology, Private Ata Health Hospital, İzmir, Turkey.
Gülistan KaradenizDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Aysu AyranciDepartment of Pulmonology, Bakırçay University Çiğli Training and Research Hospital, İzmir, Turkey.
Merve TürkDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Mine GayafDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Melike Yüksel YavuzDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Melih BüyükşirinDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Ceyda AnarDepartment of Pulmonology, Health Sciences University Dr.Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
Izmir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe most important risk factor for chronic obstructive pulmonary disease (COPD) is smoking. However, more than 25% of patients do not have a history of smoking. The intent of this study is to identify characteristics of COPD patients that are non-smokers. MATERIAL AND

methodsThe records of patients with COPD were retrospectively reviewed. Smoking history, comorbidities, exacerbations, biomass, and environmental tobacco smoke (ETS) exposures were identified. Also, age, gender, pulmonary function test (PFT) values, modified Medical Research Council (mMRC) dyspnea scores were recorded. Non-smokers exposed to any of the COPD risk factors above were grouped and the data were analyzed to determine the specific characteristics of COPD that applied to them.

resultsA total of 706 COPD patients were analyzed with a mean age of 67.2 ± 9.4. Of these patients, 93 (13.2%) were female and 613 (86.8%) were male. Of the 706 patients, 128 (18.1%) were non-smokers. The percentage of male patients having COPD was significantly lower in the non-smoker group (P < .001). However, biomass, ETS exposure in childhood, and a history of previous respiratory infection were significantly higher in the non-smoker group (P < .001). The mean body mass index (BMI) was greater in non-smokers than smokers.

conclusionNon-smokers with COPD have more biomass, ETS exposure, and infection history in childhood. They also have less impairment of airflow limitation, better symptom scores, and greater BMIs. Smoking history can be used to determine a different phenotype.

Identifiers

PMID35110244
PMCPMC8975314
OpenAlexW2969292662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.